Showing results (111-120 of 401) with videos related to
Sort By:
Pageof 41
Case Reports in Medicine|May 2, 2012
Novel BRAF Alteration in a Sporadic Pilocytic AstrocytomaSonika Dahiya, Jinsheng Yu, Aparna Kaul, et al.Expert Opinion on Investigational Drugs|February 22, 2013
Optimizing biologically targeted clinical trials for neurofibromatosisDavid H Gutmann, Jaishri O Blakeley, Bruce R Korf, et al.Developmental Medicine and Child Neurology|January 20, 2019
Adaptive functioning in children with neurofibromatosis type 1: relationship to cognition, behavior, and magnetic resonance imagingNoah S Eby, Jennifer L Griffith, David H Gutmann, et al.Oncogene|February 22, 2002
Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivoZhi-yong Huang, Rebecca L Baldwin, Nicolé M Hedrick, et al.Journal of Sleep Research|January 5, 2019
Neurofibromatosis type 1 (Nf1)-mutant mice exhibit increased sleep fragmentationCorina Anastasaki, Nicholas Rensing, Kevin J Johnson, et al.The Journal of Pain|April 13, 2013
Assessment of pain and itch behavior in a mouse model of neurofibromatosis type 1Daniel E O'Brien, Daniel S Brenner, David H Gutmann, et al.Oncotarget|April 6, 2017
Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survivalYuan Pan, Laura J Smithson, Yu Ma, et al.Molecular Cancer Therapeutics|January 11, 2011
Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytesSutapa Banerjee, Scott M Gianino, Feng Gao, et al.Journal of the American Academy of Dermatology|April 2, 2014
Glomus tumors in individuals with neurofibromatosis type 1Monique G Kumar, Ryan J Emnett, Susan J Bayliss, et al.Cancer Research|June 5, 2003
Mouse models of human cancer consortium symposium on nervous system tumorsDavid H Gutmann, Suzanne J Baker, Marco Giovannini, et al.Pageof 41